S
GILD icon

Sunpointe’s Gilead Sciences GILD Stock Holding History

Sunpointe’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$302K Sell
2,393
-128
-5% -$16.9K 0.09% 201
2026
Q1 		$351K Sell
2,521
-861
-25% -$121K 0.12% 172
2025
Q4 		$415K Sell
3,382
-23
-0.7% -$2.79K 0.14% 153
2025
Q3 		$378K Sell
3,405
-342
-9% -$38.9K 0.14% 158
2025
Q2 		$415K Buy
3,747
+55
+1% +$5.85K 0.16% 126
2025
Q1 		$414K Sell
3,692
-962
-21% -$99.3K 0.22% 88
2024
Q4 		$430K Buy
4,654
+500
+12% +$45K 0.22% 90
2024
Q3 		$348K Buy
4,154
+155
+4% +$11.8K 0.29% 91
2024
Q2 		$274K Sell
3,999
-1,001
-20% -$66.8K 0.18% 114
2024
Q1 		$366K Buy
5,000
+1,509
+43% +$116K 0.41% 78
2023
Q4 		$283K Buy
+3,491
New +$272K 0.36% 92

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sunpointe's GILD Position: Q2 2026 in Review

Sunpointe reduced its Gilead Sciences (GILD) stake by 5.1% in Q2 2026, selling an estimated $16.9K and leaving 2,393 shares worth $302K. The position accounts for 0.09% of the portfolio, ranked #201.

Sunpointe first reported a position in GILD in Q4 2023 and has held it in 11 quarters since. The position peaked at $430K in Q4 2024. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sunpointe held 2,393 shares of Gilead Sciences worth $302K as of Q2 2026.
  • Sunpointe sold 128 Gilead Sciences shares in Q2 2026, an estimated $16.9K.
  • Gilead Sciences made up 0.09% of Sunpointe's portfolio in Q2 2026, its #201 holding.
  • Sunpointe first reported a position in Gilead Sciences in Q4 2023 and has held it in 11 quarters since.
  • Sunpointe's Gilead Sciences position peaked at $430K in Q4 2024.
  • 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.